Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M40,692Revenue $M5,770Net Margin (%)-9.4Z-Score1.3
Enterprise Value $M57,596EPS $-2.7Operating Margin %1.2F-Score3
P/E(ttm))0Cash Flow Per Share $4.9Pre-tax Margin (%)-14.0Higher ROA y-yN
Price/Book8.010-y EBITDA Growth Rate %2.9Quick Ratio1.7Cash flow > EarningsY
Price/Sales5.65-y EBITDA Growth Rate %42.8Current Ratio2.1Lower Leverage y-yN
Price/Cash Flow11.8y-y EBITDA Growth Rate %49.8ROA % (ttm)-2.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-13.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M335ROI % (ttm)-4.0Gross Margin Increase y-yN

Gurus Latest Trades with VRX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRXGlenn Greenberg 2014-06-30 Add2.33%$116.99 - $138.13
($127.6)
$ 121.86-4%Add 8.19%6,050,442
VRXSteve Mandel 2014-06-30 Add0.64%$116.99 - $138.13
($127.6)
$ 121.86-4%Add 14.44%10,089,450
VRXLee Ainslie 2014-06-30 Add0.37%$116.99 - $138.13
($127.6)
$ 121.86-4%Add 8.39%2,625,014
VRXGeorge Soros 2014-06-30 Add0.29%$116.99 - $138.13
($127.6)
$ 121.86-4%Add 185.46%472,187
VRXJoel Greenblatt 2014-06-30 Buy 0.01%$116.99 - $138.13
($127.6)
$ 121.86-4%New holding, 6172 sh.6,172
VRXDaniel Loeb 2014-06-30 Sold Out -0.48%$116.99 - $138.13
($127.6)
$ 121.86-4%Sold Out0
VRXJohn Paulson 2014-06-30 Reduce-0.32%$116.99 - $138.13
($127.6)
$ 121.86-4%Reduce -49.97%500,300
VRXWallace Weitz 2014-06-30 Reduce-0.19%$116.99 - $138.13
($127.6)
$ 121.86-4%Reduce -2.91%1,551,076
VRXMariko Gordon 2014-06-30 Sold Out -0.13%$116.99 - $138.13
($127.6)
$ 121.86-4%Sold Out0
VRXLee Ainslie 2014-03-31 Add1.46%$112.62 - $148
($136.19)
$ 121.86-10%Add 48.23%2,421,778
VRXJohn Paulson 2014-03-31 Buy 0.65%$112.62 - $148
($136.19)
$ 121.86-10%New holding, 1000000 sh.1,000,000
VRXSteve Mandel 2014-03-31 Add0.61%$112.62 - $148
($136.19)
$ 121.86-10%Add 13.67%8,816,702
VRXDaniel Loeb 2014-03-31 Buy 0.48%$112.62 - $148
($136.19)
$ 121.86-10%New holding, 250000 sh.250,000
VRXGeorge Soros 2014-03-31 Buy 0.22%$112.62 - $148
($136.19)
$ 121.86-10%New holding, 165411 sh.165,411
VRXGlenn Greenberg 2014-03-31 Reduce-2.5%$112.62 - $148
($136.19)
$ 121.86-10%Reduce -8.52%5,592,558
VRXWallace Weitz 2014-03-31 Reduce-0.99%$112.62 - $148
($136.19)
$ 121.86-10%Reduce -13.61%1,597,540
VRXLou Simpson 2014-03-31 Reduce-0.25%$112.62 - $148
($136.19)
$ 121.86-10%Reduce -2.65%1,614,593
VRXMariko Gordon 2014-03-31 Reduce-0.1%$112.62 - $148
($136.19)
$ 121.86-10%Reduce -45.69%24,276
VRXLee Ainslie 2013-12-31 Buy 2.5%$103.04 - $117.42
($109.47)
$ 121.8611%New holding, 1633838 sh.1,633,838
VRXJulian Robertson 2013-12-31 Sold Out -2.5%$103.04 - $117.42
($109.47)
$ 121.8611%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VRX Joel Greenblatt 2014-06-306,17200.01New Buy
VRX George Soros 2014-06-30472,1870.140.45+185.46%
VRX Steve Mandel 2014-06-3010,089,4503.015.1+14.44%
VRX Jean-Marie Eveillard 2014-06-301,024,4020.310.31+13.5%
VRX Lee Ainslie 2014-06-302,625,0140.784.8+8.39%
VRX Glenn Greenberg 2014-06-306,050,4421.830.8+8.19%
VRX Ruane Cunniff 2014-06-3034,298,38410.2323.1+0.24%
VRX Lou Simpson 2014-06-301,615,5490.488.2+0.06%
VRX Jeff Ubben 2014-06-3018,923,8775.6417.6
VRX Wallace Weitz 2014-06-301,551,0760.465.9-2.91%
VRX John Paulson 2014-06-30500,3000.150.27-49.97%
VRX Mariko Gordon 2014-06-30000Sold Out
VRX Daniel Loeb 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-06-23Sell10,203$121.70.29view
Mirovsky PavelPresident of Valeant Europe 2014-06-02Sell10,000$131.25-7.01view
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-05-13Sell10,000$130.08-6.17view
Provencio Norma AnnDirector 2014-04-01Sell5,000$132.18-7.66view
Kornwasser LaizerEVP, Company Group Chairman 2014-03-21Buy2,481$134.97-9.57view
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-03-17Sell5,000$141.72-13.88view
Provencio Norma AnnDirector 2014-03-03Sell5,000$141.62-13.82view
Provencio Norma AnnDirector 2014-02-03Sell5,000$136.23-10.41view
Kornwasser LaizerEVP, Company Group Chairman 2014-01-24Buy2,536$132.15-7.64view
Provencio Norma AnnDirector 2014-01-13Sell5,000$133-8.23view

Press Releases about VRX :

    Quarterly/Annual Reports about VRX:

    News about VRX:

    Articles On GuruFocus.com
    Most Held Canadian Stocks of the Second Quarter Sep 04 2014 
    Valeant Pharmaceuticals Part XII: the rolling solvency calculation Sep 02 2014 
    Valeant Pharmaceuticals part XI: Less luscious lips Aug 13 2014 
    Valeant Pharmaceuticals Part X: a follow up on the sale of facial injectables Aug 11 2014 
    Diamond Hill Capital Comments on Valeant Pharmaceuticals International Inc Jul 25 2014 
    Ackman Explains Valeant Bid, Makes Up with Carl Icahn Jun 09 2014 
    The Top Guru-Held Canadian Stocks of the First Quarter May 28 2014 
    Jim Chanos on Green Mountain Short, China Short, Valeant and Short Selling May 15 2014 
    Bill Ackman Interview: Forgiving Icahn, Valeant Merger, Fannie Mae and Freddie Mac May 05 2014 
    Mario Gabelli on Bill Ackman, Valeant, AT&T, DirecTV and Pfizer May 02 2014 


    More From Other Websites
    Ackman plans Amsterdam fund IPO in Europe push Sep 15 2014
    Latisse Appeal, Scottish Web: Intellectual Property Sep 14 2014
    Will Allergan's Board Be Revamped to Aid Valeant Buyout? Sep 12 2014
    Allergan vs. Valeant: Where's Perry Mason When You Need Him? Sep 11 2014
    [video] Faber Report: Valeant submits consents Sep 11 2014
    Inversion Pioneer Ubben Delivers 17% as Quiet Activist Sep 09 2014
    Tax Inversion Pioneer Shakes Boardrooms With 17% Return Sep 09 2014
    In Letter to Botox Maker, Ackman Attacks Board Inaction on Merger Talks Sep 09 2014
    Valeant Pharmaceuticals Expands Bausch + Lomb Manufacturing Facility, Adding 120 New Jobs in... Sep 08 2014
    Valeant Pharmaceuticals Expands Bausch + Lomb Manufacturing Facility, Adding 120 New Jobs in... Sep 08 2014
    Salix, Gilead Among 5 Top Medical Leaders To Watch Sep 05 2014
    Allergan OKs Special Shareholder Meeting Consents Sep 05 2014
    Most Held Canadian Stocks of the Second Quarter Sep 04 2014
    [video] Faber Report: Allergan special meeting coming Sep 04 2014
    Today's Top Performers In Drugs Sep 02 2014
    Allergan Seeks Court Order to Stop Valeant, Affiliates Aug 28 2014
    VALEANT PHARMACEUTICALS INTERNATIONAL Financials Aug 28 2014
    [video] Legal Victory for Ackman and Valeant Pharma Aug 28 2014
    Allergan Attempts to Elude Ackman Bid Fuel Bearish Bets Aug 27 2014
    Allergan sets date for special shareholder meeting Aug 27 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK